MoCHiV

The Swiss Mother and Child HIV Cohort Study (MoCHiV) aims at preventing mother-to-child transmission and enrol HIV-infected pregnant women and their children.

[MoCHiV @MochivCohort]

Exciting #mochiv study: 1-year #postpartum follow-up of #women with #HIV in #Switzerland (2000-2018) reveal sustained viral load suppression! Key factors influencing outcomes: illicit drug use, late treatment initiation during #pregnancy, and #depression. https://t.co/18GK7mQR1h

[MoCHiV @MochivCohort]

new #mochiv study results on breastfeeding with HIV after shared decision-making: bonding and health benefits are important arguments, and none of the breastfed infants acquired HIV. This supports the Swiss recommendations since 2018. #HIV #breastfeeding https://t.co/gmYBtX2ghF

[MoCHiV @MochivCohort]

Finally, the updated cohort profile of our #Swiss #HIV Cohort Study (#SHCS) is available https://t.co/3CRHZxTg9P. Interested in any collaboration? Please please visit https://t.co/RhPgYVLFrj and https://t.co/MzwqKFcSxq.

[MoCHiV @MochivCohort]

Important editorial by Dr. Louise Kuhn. Neonatal #HIV care still a challenge. To achieve HIV #remission, infants should finally benefit from the successes of HIV treatment in adulthood. We urgently need effective, safe and simple medication for #newborns! https://t.co/a92pWFfKIj

[MoCHiV @MochivCohort]

Interesting new data on in-utero exposure to #HIV and sex differences: sex-specific innate immune selection of HIV associated with increased female susceptibility to #in_utero infection and enhanced #functional_cure potential among infected males https://t.co/fs921q1JYs

[MoCHiV @MochivCohort]

#CIPHER @iasociety: Patient‐level data 1993 - 2015, 11 #paediatric #HIV cohorts incl. @MochivCohort, outcomes of second-line #antiretroviral therapy (median switch age 8.4 years), nicely illustrates regional variability and differences to adult treatment https://t.co/d4vM886FZr

[MoCHiV @MochivCohort]

#HIV exposed uninfected #infants receiving neonatal PEP with #zidovudine showed non-significant trends of lower CD4 and CD8 T cells as well as CD19 B cells than those who didn’t, suggesting toxicity that might impact the overall health of HEU children. https://t.co/CvlLdITsAE

[BHIVA @BritishHIVAssoc]

BHIVA have made a further update to the guideline for the management of #HIV in #pregnancy and postpartum.

Read the full guideline here...

https://t.co/eHf95rKUuH

[MoCHiV @MochivCohort]

Moderated poster on coverage of changes in our database on prevention measures following current recommendations for the prevention of #HIV mother to child transmission #mtct at #EACS2019 conference. Illustrates incredible success story of most resource-rich environments!

[MoCHiV @MochivCohort]

Exciting talk at #EACS2019 by @PaioniP on neonatal post-exposure prophylaxis abandoned for the majority of #HIV-exposed infants in Switzerland after new national recommendations in 2016.

[MoCHiV @MochivCohort]

Find out more about #MoCHiV in the description of the #SHCS https://t.co/8WDp1ExbSG… (2009) or on the website https://t.co/7zZCPMUlGi. News from MoCHiV will be posted here! We have a great interest in #research collaborations. Thanks for following.